158 related articles for article (PubMed ID: 7959202)
1. A budesonide prodrug accelerates treatment of colitis in rats.
Cui N; Friend DR; Fedorak RN
Gut; 1994 Oct; 35(10):1439-46. PubMed ID: 7959202
[TBL] [Abstract][Full Text] [Related]
2. Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression.
Fedorak RN; Haeberlin B; Empey LR; Cui N; Nolen H; Jewell LD; Friend DR
Gastroenterology; 1995 Jun; 108(6):1688-99. PubMed ID: 7768373
[TBL] [Abstract][Full Text] [Related]
3. A glucocorticoid prodrug facilitates normal mucosal function in rat colitis without adrenal suppression.
McLeod AD; Fedorak RN; Friend DR; Tozer TN; Cui N
Gastroenterology; 1994 Feb; 106(2):405-13. PubMed ID: 7507873
[TBL] [Abstract][Full Text] [Related]
4. Topical anticolitic efficacy and selectivity of the glucocorticoid budesonide in a new model of acetic acid-induced acute colitis in the rat.
Fabia R; Ar'Rajab A; Willén R; Brattsand R; Erlansson M; Svensjö E
Aliment Pharmacol Ther; 1994 Aug; 8(4):433-41. PubMed ID: 7986968
[TBL] [Abstract][Full Text] [Related]
5. Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitis.
Nolen H; Fedorak RN; Friend DR
J Pharm Sci; 1995 Jun; 84(6):677-81. PubMed ID: 7562403
[TBL] [Abstract][Full Text] [Related]
6. A novel colon-specific steroid prodrug enhances sodium chloride absorption in rat colitis.
Fedorak RN; Cui N; Friend DR; Madsen KL; Empey LR
Am J Physiol; 1995 Aug; 269(2 Pt 1):G210-8. PubMed ID: 7653560
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine.
Kim I; Kong H; Lee Y; Hong S; Han J; Jung S; Jung Y; Kim YM
Pharm Res; 2009 Feb; 26(2):415-21. PubMed ID: 18958401
[TBL] [Abstract][Full Text] [Related]
8. Steady-state pharmacokinetics of corticosteroid delivery from glucuronide prodrugs in normal and colitic rats.
Nolen HW; Fedorak RN; Friend DR
Biopharm Drug Dispos; 1997 Nov; 18(8):681-95. PubMed ID: 9373725
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of altered neural function in a rat model of acute colitis.
Jacobson K; McHugh K; Collins SM
Gastroenterology; 1997 Jan; 112(1):156-62. PubMed ID: 8978354
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats.
Varshosaz J; Emami J; Fassihi A; Tavakoli N; Minaiyan M; Ahmadi F; Mahzouni P; Dorkoosh F
Int J Colorectal Dis; 2010 Oct; 25(10):1159-65. PubMed ID: 20669022
[TBL] [Abstract][Full Text] [Related]
11. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats.
Rodriguez M; Antúnez JA; Taboada C; Seijo B; Torres D
J Pharm Pharmacol; 2001 Sep; 53(9):1207-15. PubMed ID: 11578103
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery.
Haeberlin B; Rubas W; Nolen HW; Friend DR
Pharm Res; 1993 Nov; 10(11):1553-62. PubMed ID: 8290467
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis.
Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F
Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521
[TBL] [Abstract][Full Text] [Related]
15. The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice.
Ocón B; Aranda CJ; Gámez-Belmonte R; Suárez MD; Zarzuelo A; Martínez-Augustin O; Sánchez de Medina F
Biochem Pharmacol; 2016 Sep; 116():73-88. PubMed ID: 27431777
[TBL] [Abstract][Full Text] [Related]
16. Glycyrrhizin enhances therapeutic activity of a colon-specific methylprednisolone prodrug against experimental colitis.
Lee Y; Jeong S; Kim W; Kim H; Yoon JH; Jeong SH; Jung Y
Dig Dis Sci; 2013 May; 58(5):1226-34. PubMed ID: 23192646
[TBL] [Abstract][Full Text] [Related]
17. Indomethacin worsens and a leukotriene biosynthesis inhibitor accelerates mucosal healing in rat colitis.
Empey LR; Walker K; Fedorak RN
Can J Physiol Pharmacol; 1992 May; 70(5):660-8. PubMed ID: 1330256
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery.
Kim D; Kim W; Jeong S; Kim D; Yoo JW; Jung Y
Drug Deliv Transl Res; 2019 Feb; 9(1):334-343. PubMed ID: 30426357
[TBL] [Abstract][Full Text] [Related]
19. Colonic delivery of celecoxib is a potential pharmaceutical strategy for repositioning the selective COX-2 inhibitor as an anti-colitic agent.
Kim W; Lee Y; Jeong S; Nam J; Lee S; Jung Y
Arch Pharm Res; 2015 Oct; 38(10):1830-8. PubMed ID: 25860026
[TBL] [Abstract][Full Text] [Related]
20. The leukocyte recruitment inhibitor, NPC 15669 accelerates healing in acetic acid-induced colitis.
Lowe VC; Noronha-Blob L
Agents Actions; 1993; 39 Spec No():C80-2. PubMed ID: 8273594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
